Review



g5 transcutaneous sensor  (Dexcom Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Dexcom Inc g5 transcutaneous sensor
    Participant characteristics
    G5 Transcutaneous Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/g5 transcutaneous sensor/product/Dexcom Inc
    Average 90 stars, based on 1 article reviews
    g5 transcutaneous sensor - by Bioz Stars, 2026-04
    90/100 stars

    Images

    1) Product Images from "Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance"

    Article Title: Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance

    Journal: Journal of Endocrinological Investigation

    doi: 10.1007/s40618-021-01624-2

    Participant characteristics
    Figure Legend Snippet: Participant characteristics

    Techniques Used:

    Total data collected during DG5 and EVS use and percentage of use when sensor was active
    Figure Legend Snippet: Total data collected during DG5 and EVS use and percentage of use when sensor was active

    Techniques Used:

    Glycemic control during EVS and DG5 sensor use
    Figure Legend Snippet: Glycemic control during EVS and DG5 sensor use

    Techniques Used: Standard Deviation



    Similar Products

    g5 transcutaneous sensor  (Dexcom Inc)
    90
    Dexcom Inc g5 transcutaneous sensor
    Participant characteristics
    G5 Transcutaneous Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/g5 transcutaneous sensor/product/Dexcom Inc
    Average 90 stars, based on 1 article reviews
    g5 transcutaneous sensor - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    g5 mobile transcutaneous sensor  (Dexcom Inc)
    90
    Dexcom Inc g5 mobile transcutaneous sensor
    Participant characteristics
    G5 Mobile Transcutaneous Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/g5 mobile transcutaneous sensor/product/Dexcom Inc
    Average 90 stars, based on 1 article reviews
    g5 mobile transcutaneous sensor - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Participant characteristics

    Journal: Journal of Endocrinological Investigation

    Article Title: Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance

    doi: 10.1007/s40618-021-01624-2

    Figure Lengend Snippet: Participant characteristics

    Article Snippet: In a randomized crossover trial we compared 12 weeks with Eversense implantable sensor (EVS) and 12 weeks with Dexcom G5 transcutaneous sensor (DG5) in terms of accuracy, evaluated as Mean Absolute Relative Difference (MARD) vs capillary glucose (SMBG), time of CGM use, adverse events, efficacy (as HbA1c, time in range, time above and below range) and psychological outcomes evaluated with Diabetes Treatment Satisfaction Questionnaire (DTSQ), Glucose Monitoring Satisfaction Survey (GMSS), Hypoglycemia Fear Survey (HFS2), Diabetes Distress Scale (DDS).

    Techniques:

    Total data collected during DG5 and EVS use and percentage of use when sensor was active

    Journal: Journal of Endocrinological Investigation

    Article Title: Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance

    doi: 10.1007/s40618-021-01624-2

    Figure Lengend Snippet: Total data collected during DG5 and EVS use and percentage of use when sensor was active

    Article Snippet: In a randomized crossover trial we compared 12 weeks with Eversense implantable sensor (EVS) and 12 weeks with Dexcom G5 transcutaneous sensor (DG5) in terms of accuracy, evaluated as Mean Absolute Relative Difference (MARD) vs capillary glucose (SMBG), time of CGM use, adverse events, efficacy (as HbA1c, time in range, time above and below range) and psychological outcomes evaluated with Diabetes Treatment Satisfaction Questionnaire (DTSQ), Glucose Monitoring Satisfaction Survey (GMSS), Hypoglycemia Fear Survey (HFS2), Diabetes Distress Scale (DDS).

    Techniques:

    Glycemic control during EVS and DG5 sensor use

    Journal: Journal of Endocrinological Investigation

    Article Title: Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance

    doi: 10.1007/s40618-021-01624-2

    Figure Lengend Snippet: Glycemic control during EVS and DG5 sensor use

    Article Snippet: In a randomized crossover trial we compared 12 weeks with Eversense implantable sensor (EVS) and 12 weeks with Dexcom G5 transcutaneous sensor (DG5) in terms of accuracy, evaluated as Mean Absolute Relative Difference (MARD) vs capillary glucose (SMBG), time of CGM use, adverse events, efficacy (as HbA1c, time in range, time above and below range) and psychological outcomes evaluated with Diabetes Treatment Satisfaction Questionnaire (DTSQ), Glucose Monitoring Satisfaction Survey (GMSS), Hypoglycemia Fear Survey (HFS2), Diabetes Distress Scale (DDS).

    Techniques: Standard Deviation